Company profile
Heart Tronics, Inc.
OTC: HRTT · Healthcare · Medical - Devices
PublicHQ Studio City, CAReports USD
#1161 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
——FH —DQ —GM —SS 39
v0.1 · 5/100 weight · pillars only
↑ listing tenure, balance-sheet leverage · ↓ market scale, revenue growth (YoY)
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$13.3M
Employees
13
as of 2026-08-31
Market cap
$56
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02007
Net income-$13.3M-$13.3M2007
Operating income$14.5M$14.5M2007
Total assets$4.0M$4.0M2007
Liabilities$1.1M$1.1M2007
Equity$3.0M$3.0M2007
Revenue trend
FY2000 – FY2007 · USD
FY00
FY01
FY02
FY03
FY04
FY05
FY06
FY07
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Heart Tronics, Inc.’s revenue?
Heart Tronics, Inc. booked $0 in FY2007 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Poniard Pharmaceuticals, Inc.——NexImmune, Inc.——ContraFect Corp.——Nuvalent, Inc.——Apogee Therapeutics, Inc.——Immunovant, Inc.——Key facts
CEOJames N. Fiedler
SectorHealthcare
IndustryMedical - Devices
HeadquartersStudio City, CA
ExchangeOTC: HRTT
Employees13
IPO date1999-10-27
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.